“Metamizole-Induced Agranulocytosis: Utilisation Trends, Pharmacovigilance Signals and Regulatory Risk-Minimisation in Switzerland”. Swiss Medical Weekly, vol. 156, no. 6, June 2026, p. 5062, https://doi.org/10.57187/5062.